Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd)- are Current Models Suitable to Evaluate Personalized Medicine
Abstract
Authors
M Hoogendoorn T Feenstra Y Asukai A Briggs S Borg R dal Negro RN Hansen S Jansson M Wacker N Risebrough Y Samyshkin R Leidl M Rutten van-Mölken